A simple tool has been developed to predict the delayed neurotoxicity that occurs in about half of patients who undergo CAR T-cell therapy. The score – based on readily available clinical and laboratory measures – will allow observation and treatment to be targeted at those most at risk, allowing low risk patients to be discharged ...
Tool can predict CAR T-cell therapy neurotoxicity
By Michael Woodhead
11 Aug 2020